idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
04/06/2006 11:05

Prof. Walter Birchmeier new Scientific Director of the Max Delbrück Center

Barbara Bachtler Kommunikation
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch

    Prof. Walter Birchmeier is the new Scientific Director of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. The MDC Board of Trustees appointed him to the position for a period of three years, effective as of January 1, 2006. As the former deputy chairman of the MDC Executive Board, Prof. Birchmeier had served as interim director since April 2004. As Scientific Director, his aim will be to strengthen research in molecular medicine and, in particular, to promote the collaboration between basic and clinical researchers. Through a collaboration between the MDC and the Charité Medical School Berlin, he plans to establish an Experimental and Clinical Research Center (ECRC) devoted to translational research.

    Through his own research at the MDC, Prof. Walter Birchmeier has been promoting the concept of molecular medicine for many years. Disturbances in one gene or pathway often affect various organs and can result in severe disease. Molecular-oriented research, the aim of which is to understand basic mechanisms of disease processes, must, therefore, extend across the boundaries of traditional medicine.

    In the early 1980s, Walter Birchmeier's laboratory discovered a molecule required for the adhesion of epithelial cells. The group went on to identify the mechanism by which this molecule is down-regulated in cancer, leading to a disruption of epithelial organization and the generation of invasive and metastatic tumor cells. Further important findings of his research were the identification of signaling molecules which transmit information from the cell surface to the nucleus. Such molecules play critical roles in both tumorigenesis, as well as in other diseases, such as in cardiomyopathies. Furthermore, he showed that certain signal transduction pathways control development of the nervous system, production of stem cells in the skin, as well as the formation of internal organs.

    Prof. Birchmeier has published more than one hundred scientific articles and received several awards for his work including the Wilhelm Warner Prize for Cancer Research in 1990, the Meyenburg Prize for Cancer Research in 1992, and the German Cancer Prize in 1999. He is a member of the European Molecular Biology Organization (EMBO) and a corresponding member of the Swiss Academy of Medical Sciences (SAMS).

    Walter Birchmeier was born on July 8, 1943 in Würenlingen (Aargau Canton), Switzerland. After working as an elementary school teacher, he studied biology at the University of Zürich where he received his PhD degree. He moved to the United States in 1973 to do postdoctoral research, first with Jeff Schatz at Cornell University, Ithaca, New York, and later with Jon Singer at the University of California in San Diego. He returned to Europe in 1979, accepting a position at the Eidgenössische Technische Hochschule (ETH) Zürich, Switzerland, and, in 1982, went to work as the head of a research group at the Friedrich Miescher Laboratory of the Max-Planck-Gesellschaft in Tübingen, Germany. In 1988, he was appointed as Full Professor for Molecular Cell Biology at the University Clinic in Essen, Germany. He has lead his research group at the MDC since 1993 and was appointed professor at the Charité Medical School Berlin in 1996. In 1998, he became Deputy Scientific Director of the MDC.

    Founded in 1992, the MDC conducts interdisciplinary research into cancer, cardiovascular diseases, and neurological disorders (Molecular Medicine). Scientists at the MDC apply molecular biology and genetic engineering to study genes and their products (i.e., proteins) and their role in the onset of complex diseases. Combining basic and clinical research, MDC scientists collaborate closely with clinicians of the Charité University Medicine and the Helios Klinikum Berlin-Buch. The MDC is a member of the Helmholtz Association of National Research Centres and employs a staff of 750. It receives 90 per cent of its funding from the German Federal Ministry of Education and Research (BMBF), and 10 per cent from the state (Land) of Berlin.

    Press and Public Affairs
    Max Delbrück Center for Molecular Medicine(MDC) Berlin-Buch
    Barbara Bachtler
    Robert-Rössle-Str. 10; D-13125 Berlin
    Phone: +49/30/9406-38 96
    Fax.: +49/30/9406-38 33
    e-mail: bachtler@mdc-berlin.de
    http://www.mdc-berlin.de/englisch/about_the_mdc/public_relations/e_index.htm


    Images

    Prof. Walter Birchmeier new Scientific Director of the Max Delbrück Center in Berlin
    Prof. Walter Birchmeier new Scientific Director of the Max Delbrück Center in Berlin
    Photo: David Ausserhofer/Copyright: MDC
    None


    Criteria of this press release:
    Biology, Information technology, Medicine, Nutrition / healthcare / nursing
    regional
    Personnel announcements
    English


     

    Prof. Walter Birchmeier new Scientific Director of the Max Delbrück Center in Berlin


    For download

    x

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).